Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits.

Corso S, Isella C, Bellomo SE, Apicella M, Durando S, Migliore C, Ughetto S, D'Errico L, Menegon S, Moya-Rull D, Cargnelutti M, Capeloa T, Conticelli D, Giordano J, Venesio T, Balsamo A, Marchiò C, Degiuli M, Reddavid R, Fumagalli Romario U, de Pascale S, Sgroi G, Rausa E, Baiocchi GL, Molfino S, Pietrantonio F, Morano F, Siena S, Sartore-Bianchi A, Bencivenga M, Mengardo V, Rosati R, Marrelli D, Morgagni P, Rausei S, Pallabazzer G, De Simone M, Ribero D, Marsoni S, Sottile A, Medico E, Cassoni P, Sapino A, Pectasides E, Thorner AR, Nag A, Drinan SD, Wollison BM, Bass AJ, Giordano S.

Cancer Res. 2019 Oct 4. pii: canres.1166.2019. doi: 10.1158/0008-5472.CAN-19-1166. [Epub ahead of print]

PMID:
31585941
2.

Correction to: Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.

Spinoglio G, Bianchi PP, Marano A, Priora F, Lenti LM, Ravazzoni F, Petz W, Borin S, Ribero D, Formisano G, Bertani E.

Ann Surg Oncol. 2019 Feb 25. doi: 10.1245/s10434-019-07267-1. [Epub ahead of print]

PMID:
30805803
3.

Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features.

Giannini V, Mazzetti S, Bertotto I, Chiarenza C, Cauda S, Delmastro E, Bracco C, Di Dia A, Leone F, Medico E, Pisacane A, Ribero D, Stasi M, Regge D.

Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):878-888. doi: 10.1007/s00259-018-4250-6. Epub 2019 Jan 13.

PMID:
30637502
4.

Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.

Spinoglio G, Bianchi PP, Marano A, Priora F, Lenti LM, Ravazzoni F, Petz W, Borin S, Ribero D, Formisano G, Bertani E.

Ann Surg Oncol. 2018 Nov;25(12):3580-3586. doi: 10.1245/s10434-018-6752-7. Epub 2018 Sep 14. Erratum in: Ann Surg Oncol. 2019 Feb 25;:.

PMID:
30218248
5.

Double indocyanine green technique of robotic right colectomy: Introduction of a new technique.

Kobiela J, Bertani E, Petz W, Crosta C, De Roberto G, Borin S, Ribero D, Baldassari D, Spychalski P, Spinoglio G.

J Minim Access Surg. 2019 Oct-Dec;15(4):357-359. doi: 10.4103/jmas.JMAS_127_18.

6.

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.

Peraldo-Neia C, Ostano P, Cavalloni G, Pignochino Y, Sangiolo D, De Cecco L, Marchesi E, Ribero D, Scarpa A, De Rose AM, Giuliani A, Calise F, Raggi C, Invernizzi P, Aglietta M, Chiorino G, Leone F.

BMC Genomics. 2018 Jun 5;19(1):440. doi: 10.1186/s12864-018-4829-0.

7.

The role of multimodal treatment in patients with advanced lung neuroendocrine tumors.

Fazio N, Ungaro A, Spada F, Cella CA, Pisa E, Barberis M, Grana C, Zerini D, Bertani E, Ribero D, Funicelli L, Bonomo G, Ravizza D, Guarize J, De Marinis F, Petrella F, Del Signore E, Pelosi G, Spaggiari L.

J Thorac Dis. 2017 Nov;9(Suppl 15):S1501-S1510. doi: 10.21037/jtd.2017.06.14. Review.

8.

Suprapubic approach for robotic complete mesocolic excision in right colectomy: Oncologic safety and short-term outcomes of an original technique.

Petz W, Ribero D, Bertani E, Borin S, Formisano G, Esposito S, Spinoglio G, Bianchi PP.

Eur J Surg Oncol. 2017 Nov;43(11):2060-2066. doi: 10.1016/j.ejso.2017.07.020. Epub 2017 Aug 10.

PMID:
28912072
9.

Robotic right colectomy with complete mesocolic excision: bottom-to-up suprapubic approach - a video vignette.

Petz W, Ribero D, Bertani E, Formisano G, Spinoglio G, Bianchi PP.

Colorectal Dis. 2017 Aug;19(8):788-789. doi: 10.1111/codi.13790. No abstract available.

PMID:
28667688
10.

Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors.

Martins D, Spada F, Lambrescu I, Rubino M, Cella C, Gibelli B, Grana C, Ribero D, Bertani E, Ravizza D, Bonomo G, Funicelli L, Pisa E, Zerini D, Fazio N; IEO ENETS Center of Excellence for GEP NETs.

Target Oncol. 2017 Oct;12(5):611-622. doi: 10.1007/s11523-017-0506-5. Review.

PMID:
28634872
11.

High-risk human papillomavirus in anal squamous cell carcinoma: a 'conservative' leading role.

Ravenda PS, Zampino MG, Guerini-Rocco E, Chiocca S, Dell'Acqua V, Trovato C, Biffi R, Ribero D, Spada F, Cella CA, Fazio N.

Ann Oncol. 2017 May 1;28(5):1160. doi: 10.1093/annonc/mdx032. No abstract available.

PMID:
28453691
12.

Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases.

Rachman-Tzemah C, Zaffryar-Eilot S, Grossman M, Ribero D, Timaner M, Mäki JM, Myllyharju J, Bertolini F, Hershkovitz D, Sagi I, Hasson P, Shaked Y.

Cell Rep. 2017 Apr 25;19(4):774-784. doi: 10.1016/j.celrep.2017.04.005.

13.

Current Status on Cholangiocarcinoma and Gallbladder Cancer.

Ebata T, Ercolani G, Alvaro D, Ribero D, Di Tommaso L, Valle JW.

Liver Cancer. 2016 Nov;6(1):59-65. Epub 2016 Nov 29. Review.

14.

Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.

Bertani E, Fazio N, Radice D, Zardini C, Spinoglio G, Chiappa A, Ribero D, Biffi R, Partelli S, Falconi M.

Eur J Surg Oncol. 2017 Feb;43(2):372-379. doi: 10.1016/j.ejso.2016.09.011. Epub 2016 Sep 30.

PMID:
27742480
15.

Notes of robotic surgical technique: four ways to mobilize splenic flexure.

Petz W, Ribero D, Bertani E, Polizzi ML, Spinoglio G.

Minerva Chir. 2016 Oct;71(5):345-8. Epub 2016 Jul 14.

PMID:
27412233
16.

Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.

Ribero D, Zimmitti G, Aloia TA, Shindoh J, Fabio F, Amisano M, Passot G, Ferrero A, Vauthey JN.

J Am Coll Surg. 2016 Jul;223(1):87-97. doi: 10.1016/j.jamcollsurg.2016.01.060. Epub 2016 Feb 13.

17.

Improving results of surgery for fecal peritonitis due to perforated colorectal disease: A single center experience.

Mineccia M, Zimmitti G, Ribero D, Giraldi F, Bertolino F, Brambilla R, Ferrero A.

Int J Surg. 2016 Jan;25:91-7. doi: 10.1016/j.ijsu.2015.11.028. Epub 2015 Nov 27.

18.

The genomic landscape of response to EGFR blockade in colorectal cancer.

Bertotti A, Papp E, Jones S, Adleff V, Anagnostou V, Lupo B, Sausen M, Phallen J, Hruban CA, Tokheim C, Niknafs N, Nesselbush M, Lytle K, Sassi F, Cottino F, Migliardi G, Zanella ER, Ribero D, Russolillo N, Mellano A, Muratore A, Paraluppi G, Salizzoni M, Marsoni S, Kragh M, Lantto J, Cassingena A, Li QK, Karchin R, Scharpf R, Sartore-Bianchi A, Siena S, Diaz LA Jr, Trusolino L, Velculescu VE.

Nature. 2015 Oct 8;526(7572):263-7. doi: 10.1038/nature14969. Epub 2015 Sep 30.

19.

Intrahepatic cholangiocarcinoma: expert consensus statement.

Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM.

HPB (Oxford). 2015 Aug;17(8):669-80. doi: 10.1111/hpb.12441.

20.

Reply to Letter: "Measured Versus Estimated Total Liver Volume to Preoperatively Assess the Adequacy of Future Liver Remnant: Which Method Should We Use?".

Ribero D, Forchino F, Capussotti L.

Ann Surg. 2015 Aug;262(2):e72-3. doi: 10.1097/SLA.0000000000000547. No abstract available.

PMID:
26164436
21.

Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.

Marino D, Leone F, D'Avanzo F, Ribero D, Capussotti L, Aglietta M.

Crit Rev Oncol Hematol. 2014 Dec;92(3):218-26. doi: 10.1016/j.critrevonc.2014.05.010. Epub 2014 Jun 8. Review.

22.

Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.

Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, Javle M, Conrad C, Maru DM, Aoki T, Vigano L, Ribero D, Kokudo N, Capussotti L, Vauthey JN.

Ann Surg. 2015 Apr;261(4):733-9. doi: 10.1097/SLA.0000000000000728.

23.

Targeted agents: how can we improve the outcome in biliary tract cancer?

Marino D, Colombi F, Ribero D, Aglietta M, Leone F.

Hepatobiliary Surg Nutr. 2013 Feb;2(1):31-3. doi: 10.3978/j.issn.2304-3881.2012.09.03. No abstract available.

24.

Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications.

Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G, Aloia TA.

J Am Coll Surg. 2013 Dec;217(6):1028-37. doi: 10.1016/j.jamcollsurg.2013.07.392.

25.

Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use?

Ribero D, Amisano M, Bertuzzo F, Langella S, Lo Tesoriere R, Ferrero A, Regge D, Capussotti L.

Ann Surg. 2013 Nov;258(5):801-6; discussion 806-7. doi: 10.1097/SLA.0000000000000213.

26.

Prognostic factors after resection of colorectal liver metastases: from morphology to biology.

Ribero D, Viganò L, Amisano M, Capussotti L.

Future Oncol. 2013 Jan;9(1):45-57. doi: 10.2217/fon.12.159. Review.

PMID:
23252563
27.

External tube pancreatostomy reduces the risk of mortality associated with completion pancreatectomy for symptomatic fistulas complicating pancreaticoduodenectomy.

Ribero D, Amisano M, Zimmitti G, Giraldi F, Ferrero A, Capussotti L.

J Gastrointest Surg. 2013 Feb;17(2):332-8. doi: 10.1007/s11605-012-2100-6. Epub 2012 Dec 1.

PMID:
23207684
28.

A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6.

Marchiò S, Soster M, Cardaci S, Muratore A, Bartolini A, Barone V, Ribero D, Monti M, Bovino P, Sun J, Giavazzi R, Asioli S, Cassoni P, Capussotti L, Pucci P, Bugatti A, Rusnati M, Pasqualini R, Arap W, Bussolino F.

EMBO Mol Med. 2012 Nov;4(11):1156-75. doi: 10.1002/emmm.201101164. Epub 2012 Oct 16.

29.

Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy.

Macera A, Lario C, Petracchini M, Gallo T, Regge D, Floriani I, Ribero D, Capussotti L, Cirillo S.

Eur Radiol. 2013 Mar;23(3):739-47. doi: 10.1007/s00330-012-2658-0. Epub 2012 Sep 14.

30.

Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.

Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA; International Cooperative Study Group on Hepatocellular Carcinoma.

J Gastrointest Surg. 2013 Jan;17(1):66-77; discussion p.77. doi: 10.1007/s11605-012-2005-4. Epub 2012 Sep 5.

31.

Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients.

Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis M, Amisano M, Berloco P, Torzilli G, Capussotti L; Italian Intrahepatic Cholangiocarcinoma Study Group.

Arch Surg. 2012 Dec;147(12):1107-13. doi: 10.1001/archsurg.2012.1962.

PMID:
22910846
32.

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, Corà D, Di Nicolantonio F, Buscarino M, Petti C, Ribero D, Russolillo N, Muratore A, Massucco P, Pisacane A, Molinaro L, Valtorta E, Sartore-Bianchi A, Risio M, Capussotti L, Gambacorta M, Siena S, Medico E, Sapino A, Marsoni S, Comoglio PM, Bardelli A, Trusolino L.

Cancer Discov. 2011 Nov;1(6):508-23. doi: 10.1158/2159-8290.CD-11-0109. Epub 2011 Sep 2.

33.

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.

Cancer. 2012 Oct 1;118(19):4737-47. doi: 10.1002/cncr.27492. Epub 2012 Mar 13.

34.

Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas.

Migliardi G, Sassi F, Torti D, Galimi F, Zanella ER, Buscarino M, Ribero D, Muratore A, Massucco P, Pisacane A, Risio M, Capussotti L, Marsoni S, Di Nicolantonio F, Bardelli A, Comoglio PM, Trusolino L, Bertotti A.

Clin Cancer Res. 2012 May 1;18(9):2515-25. doi: 10.1158/1078-0432.CCR-11-2683. Epub 2012 Mar 5.

35.

Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients.

Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, Bresadola F, Calise F, Dalla Valle R, D'Amico DF, Gennari L, Giulini SM, Guglielmi A, Jovine E, Pellicci R, Pernthaler H, Pinna AD, Puleo S, Torzilli G, Capussotti L; Italian Chapter of the International Hepato-Pancreato-Biliary Association, Cillo U, Ercolani G, Ferrucci M, Mastrangelo L, Portolani N, Pulitanò C, Ribero D, Ruzzenente A, Scuderi V, Federico B.

Arch Surg. 2012 Jan;147(1):26-34. doi: 10.1001/archsurg.2011.771.

PMID:
22250108
36.

Heterotopic spleen within the gastric wall mimicking a GIST: report of a case.

Mineccia M, Ribero D, De Rosa G, Fornari A, Capussotti L.

Updates Surg. 2013 Mar;65(1):67-70. doi: 10.1007/s13304-011-0128-x. Epub 2012 Jan 14. No abstract available.

PMID:
22246651
37.

Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.

Ribero D, Amisano M, Lo Tesoriere R, Rosso S, Ferrero A, Capussotti L.

Ann Surg. 2011 Nov;254(5):776-81; discussion 781-3. doi: 10.1097/SLA.0b013e3182368f85.

PMID:
22042470
38.

Chemotherapy between the first and second stages of a two-stage hepatectomy for colorectal liver metastases: should we routinely recommend it?

Muratore A, Zimmitti G, Ribero D, Mellano A, Viganò L, Capussotti L.

Ann Surg Oncol. 2012 Apr;19(4):1310-5. doi: 10.1245/s10434-011-2069-5. Epub 2011 Sep 23.

PMID:
21947627
39.

Intraoperative epidural analgesia prevents the early proinflammatory response to surgical trauma. Results from a prospective randomized clinical trial of intraoperative epidural versus general analgesia.

Moselli NM, Baricocchi E, Ribero D, Sottile A, Suita L, Debernardi F.

Ann Surg Oncol. 2011 Oct;18(10):2722-31. doi: 10.1245/s10434-011-1700-9. Epub 2011 Apr 9.

PMID:
21479690
40.

Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.

Galimi F, Torti D, Sassi F, Isella C, Corà D, Gastaldi S, Ribero D, Muratore A, Massucco P, Siatis D, Paraluppi G, Gonella F, Maione F, Pisacane A, David E, Torchio B, Risio M, Salizzoni M, Capussotti L, Perera T, Medico E, Di Renzo MF, Comoglio PM, Trusolino L, Bertotti A.

Clin Cancer Res. 2011 May 15;17(10):3146-56. doi: 10.1158/1078-0432.CCR-10-3377. Epub 2011 Mar 29.

41.

Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma.

Ribero D, Nuzzo G, Amisano M, Tomatis M, Guglielmi A, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Pinna AD, Capussotti L; Italian Chapter of IHPBA.

HPB (Oxford). 2011 Mar;13(3):198-205. doi: 10.1111/j.1477-2574.2010.00271.x. Epub 2011 Feb 9.

42.

Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis.

de Jong MC, van Vledder MG, Ribero D, Hubert C, Gigot JF, Choti MA, Schulick RD, Capussotti L, Dejong CH, Pawlik TM.

J Gastrointest Surg. 2011 Feb;15(2):336-44. doi: 10.1007/s11605-010-1391-8. Epub 2010 Nov 25.

PMID:
21108017
43.

Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.

Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D, Motta M, Ravarino N, Risio M, Curley SA, Abdalla EK, Capussotti L, Vauthey JN.

Ann Surg Oncol. 2010 Nov;17(11):2870-6. doi: 10.1245/s10434-010-1166-1. Epub 2010 Jun 22.

PMID:
20567921
44.

Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients.

Nathan H, de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Gigot JF, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM.

J Am Coll Surg. 2010 May;210(5):755-64, 764-6. doi: 10.1016/j.jamcollsurg.2009.12.041.

PMID:
20421045
45.

Resection margin and recurrence-free survival after liver resection of colorectal metastases.

Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L.

Ann Surg Oncol. 2010 May;17(5):1324-9. doi: 10.1245/s10434-009-0770-4. Epub 2009 Oct 22.

PMID:
19847565
46.

Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.

de Jong MC, Mayo SC, Pulitano C, Lanella S, Ribero D, Strub J, Hubert C, Gigot JF, Schulick RD, Choti MA, Aldrighetti L, Mentha G, Capussotti L, Pawlik TM.

J Gastrointest Surg. 2009 Dec;13(12):2141-51. doi: 10.1007/s11605-009-1050-0. Epub 2009 Oct 1.

PMID:
19795176
47.

Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers.

Massucco P, Ribero D, Sgotto E, Mellano A, Muratore A, Capussotti L.

Ann Surg Oncol. 2009 Dec;16(12):3323-32. doi: 10.1245/s10434-009-0672-5. Epub 2009 Sep 24.

PMID:
19777195
48.

Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.

de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM.

Ann Surg. 2009 Sep;250(3):440-8. doi: 10.1097/SLA.0b013e3181b4539b.

PMID:
19730175
49.

Is embolization of segment 4 portal veins before extended right hepatectomy justified?

Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, Vauthey JN.

Surgery. 2008 Nov;144(5):744-51. doi: 10.1016/j.surg.2008.05.015. Epub 2008 Aug 10.

50.

Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.

Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero D, Abdalla EK, Choti MA, Kemp C, Vauthey JN, Morse MA, White RR, Clary BM.

Ann Surg Oncol. 2009 Jul;16(7):1809-19. doi: 10.1245/s10434-008-0181-y. Epub 2008 Nov 1.

PMID:
18979139

Supplemental Content

Loading ...
Support Center